Accessibility Menu
China Medicine logo

China Medicine(OTC) CHME

Market Cap$1.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-98%
5 Year+488%
1 Year+9,700%
1 Month+194%
$0.06
+0.00%
+0.00Today
China Medicine last closing stock price
MetricPriceDate
Last closeUSD 0.062026-09-04
China Medicine stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-9.12%USD 0.062026-08-28
1 month+194%USD 0.022026-08-04
3 month+194%USD 0.022026-04-02
Year to date+47%USD 0.042025-12-31
1 year+9,700%USD 0.002025-08-13
3 year+9,700%USD 0.002023-08-24
5 year+488%USD 0.012021-09-01
Since inception-97.65%USD 2.502006-11-30

China Medicine Financials at a Glance

Market Cap

$1.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$34.74M

Net Income (TTM)

$6.31M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-9.08 (Low)

Price

$0.06

Volume

690

Open

$0.06

Previous Close

$0.06

Daily Range

$0.06 - $0.06

52-Week Range

$0.00 - $0.07

Estimated Earnings Date

Nov 9, 2022

CHME News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About China Medicine

China Medicine Corp. is a prominent player in the healthcare sector, specializing in the production and distribution of prescription and over-the-counter drugs, traditional Chinese medicine products, and medical devices. The company operates a comprehensive sales network throughout China, catering to various medical needs.

Products and Services
  • Prescription and over-the-counter pharmaceuticals
  • Traditional Chinese medicine and dietary supplements
  • Medical devices and formulations for various health conditions
Growth Outlook
  • Expanding product range to meet diverse healthcare needs
  • Increasing demand for traditional Chinese medicine in domestic and international markets
  • Strategic partnerships to enhance distribution capabilities
Financial Highlights
  • Recent quarterly net income of -$8,550, indicating ongoing operational challenges
  • Trailing twelve months (TTM) revenue remains at $0, reflecting a need for strategic financial adjustments
  • Market capitalization of approximately $486,097, suggesting potential for growth
China Medicine Corp. has established itself as a significant entity in the pharmaceutical industry, focusing on a diverse array of healthcare products. The company’s commitment to traditional Chinese medicine aligns with growing consumer interest in holistic health solutions. Despite recent financial challenges, including a net income loss in the latest quarter, the company’s market capitalization indicates a foundation for potential growth. The strategic expansion of product offerings and partnerships may position China Medicine Corp. favorably in the evolving healthcare landscape. Investors may find the company's focus on traditional medicine and its extensive distribution network noteworthy as it navigates current operational hurdles.
AI Generated • Aug 26, 2026

Industry

Pharmaceuticals

CEO

Senshan Yang

Headquarters

Guangzhou, GD 510006, CN

CHME Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

0.00%

Return on Capital

-0.01%

Return on Assets

0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

23.80M

Volume

690

Avg. Volume

10.72K

Financials (TTM)

Gross Profit

$11.91M

Operating Income

$6.26M

EBITDA

$7.15M

Operating Cash Flow

$11.01M

Capital Expenditure

-$4.58M

Free Cash Flow

$6.43M

Cash & ST Invst.

$7.85M

Total Debt

$3.20M

China Medicine Performance Analysis

China Medicine annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
China Medicine sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22010-06-3062.6%
Q32010-09-302.1%
Q12026-03-31N/A
Q22026-06-30N/A
China Medicine annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.00N/A
20252025-12-31USD -0.00N/A
China Medicine sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22010-06-30N/A
Q32010-09-30-40.0%
Q12026-03-31N/A
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.98K

N/A

Employees

281

N/A

Net Income

-$8.55K

-100.5%

EBITDA

-$8.55K

-100.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$7.85M

+250.2%

Total Debt

$3.20M

+9.1%

Accounts Receivable

$17.27M

+2.5%

Inventory

$5.87M

-26.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$3.20M

+9.1%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

-$4.78M

-337.8%

Operating Cash Flow

-$346.56K

-117.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PCYNProcyon Corporation
$0.25+0.00%
PPJEPPJ Healthcare Enterprises, Inc.
$0.00+0.00%
TBIOTelesis Bio, Inc.
$0.00+0.00%
CTTHCTT Pharmaceutical Holdings, Inc.
$0.05-3.06%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About CHME

What is the current price of China Medicine?

China Medicine is trading at $0.06 per share.

What is the 52-week range for China Medicine?

Over the past 52 weeks, China Medicine has traded between $0.00 and $0.07.

How much debt does China Medicine have?

As of the most recent reporting period, China Medicine reported total debt of $0.00.

How much cash does China Medicine have on hand?

China Medicine reported $0.00 in cash and cash equivalents in its most recent financial results.

What is China Medicine’s dividend yield?

China Medicine does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.